Report Detail
Global Dermatological Therapeutics Market Insights, Forecast to 2025
- RnM2700307 |
- 14 June, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
The global Dermatological Therapeutics market is valued at 53 million US$ in 2018 and will reach 100 million US$ by the end of 2025, growing at a CAGR of 8.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dermatological Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Dermatological Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dermatological Therapeutics in these regions.
This research report categorizes the global Dermatological Therapeutics market by top players/brands, region, type and end user. This report also studies the global Dermatological Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AGI Dermatics
Allergan
Amgen
Chester Valley
Dermik
Eisai
Ferndale
Genentech
Medicis
Onset Therapeutics
Market size by Product
Anti-infectives
Corticosteroids
Anti Psoriasis
Anti-acne
Others
Market size by End User
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dermatological Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dermatological Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dermatological Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dermatological Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dermatological Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dermatological Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dermatological Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dermatological Therapeutics Market Size Growth Rate by Product
- 1.4.2 Anti-infectives
- 1.4.3 Corticosteroids
- 1.4.4 Anti Psoriasis
- 1.4.5 Anti-acne
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Dermatological Therapeutics Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dermatological Therapeutics Market Size
- 2.1.1 Global Dermatological Therapeutics Revenue 2014-2025
- 2.1.2 Global Dermatological Therapeutics Sales 2014-2025
- 2.2 Dermatological Therapeutics Growth Rate by Regions
- 2.2.1 Global Dermatological Therapeutics Sales by Regions
- 2.2.2 Global Dermatological Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dermatological Therapeutics Sales by Manufacturers
- 3.1.1 Dermatological Therapeutics Sales by Manufacturers
- 3.1.2 Dermatological Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Dermatological Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Dermatological Therapeutics Revenue by Manufacturers
- 3.2.1 Dermatological Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Dermatological Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Dermatological Therapeutics Price by Manufacturers
- 3.4 Dermatological Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Dermatological Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dermatological Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Dermatological Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dermatological Therapeutics Sales by Product
- 4.2 Global Dermatological Therapeutics Revenue by Product
- 4.3 Dermatological Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dermatological Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Dermatological Therapeutics by Countries
- 6.1.1 North America Dermatological Therapeutics Sales by Countries
- 6.1.2 North America Dermatological Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dermatological Therapeutics by Product
- 6.3 North America Dermatological Therapeutics by End User
7 Europe
- 7.1 Europe Dermatological Therapeutics by Countries
- 7.1.1 Europe Dermatological Therapeutics Sales by Countries
- 7.1.2 Europe Dermatological Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dermatological Therapeutics by Product
- 7.3 Europe Dermatological Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Dermatological Therapeutics by Countries
- 8.1.1 Asia Pacific Dermatological Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Dermatological Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dermatological Therapeutics by Product
- 8.3 Asia Pacific Dermatological Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Dermatological Therapeutics by Countries
- 9.1.1 Central & South America Dermatological Therapeutics Sales by Countries
- 9.1.2 Central & South America Dermatological Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dermatological Therapeutics by Product
- 9.3 Central & South America Dermatological Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dermatological Therapeutics by Countries
- 10.1.1 Middle East and Africa Dermatological Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Dermatological Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dermatological Therapeutics by Product
- 10.3 Middle East and Africa Dermatological Therapeutics by End User
11 Company Profiles
- 11.1 AGI Dermatics
- 11.1.1 AGI Dermatics Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AGI Dermatics Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AGI Dermatics Dermatological Therapeutics Products Offered
- 11.1.5 AGI Dermatics Recent Development
- 11.2 Allergan
- 11.2.1 Allergan Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Allergan Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Allergan Dermatological Therapeutics Products Offered
- 11.2.5 Allergan Recent Development
- 11.3 Amgen
- 11.3.1 Amgen Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Amgen Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Amgen Dermatological Therapeutics Products Offered
- 11.3.5 Amgen Recent Development
- 11.4 Chester Valley
- 11.4.1 Chester Valley Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Chester Valley Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Chester Valley Dermatological Therapeutics Products Offered
- 11.4.5 Chester Valley Recent Development
- 11.5 Dermik
- 11.5.1 Dermik Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Dermik Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Dermik Dermatological Therapeutics Products Offered
- 11.5.5 Dermik Recent Development
- 11.6 Eisai
- 11.6.1 Eisai Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Eisai Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Eisai Dermatological Therapeutics Products Offered
- 11.6.5 Eisai Recent Development
- 11.7 Ferndale
- 11.7.1 Ferndale Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Ferndale Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Ferndale Dermatological Therapeutics Products Offered
- 11.7.5 Ferndale Recent Development
- 11.8 Genentech
- 11.8.1 Genentech Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Genentech Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Genentech Dermatological Therapeutics Products Offered
- 11.8.5 Genentech Recent Development
- 11.9 Medicis
- 11.9.1 Medicis Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Medicis Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Medicis Dermatological Therapeutics Products Offered
- 11.9.5 Medicis Recent Development
- 11.10 Onset Therapeutics
- 11.10.1 Onset Therapeutics Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Onset Therapeutics Dermatological Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Onset Therapeutics Dermatological Therapeutics Products Offered
- 11.10.5 Onset Therapeutics Recent Development
12 Future Forecast
- 12.1 Dermatological Therapeutics Market Forecast by Regions
- 12.1.1 Global Dermatological Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dermatological Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Dermatological Therapeutics Market Forecast by Product
- 12.2.1 Global Dermatological Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Dermatological Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Dermatological Therapeutics Market Forecast by End User
- 12.4 North America Dermatological Therapeutics Forecast
- 12.5 Europe Dermatological Therapeutics Forecast
- 12.6 Asia Pacific Dermatological Therapeutics Forecast
- 12.7 Central & South America Dermatological Therapeutics Forecast
- 12.8 Middle East and Africa Dermatological Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dermatological Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dermatological Therapeutics . Industry analysis & Market Report on Dermatological Therapeutics is a syndicated market report, published as Global Dermatological Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dermatological Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
